PRM’s Center of Excellence for Endometriosis Expands in Dallas and Houston
Dallas, TX, June 10, 2025 (GLOBE NEWSWIRE) — Dallas, TX (June 10, 2025) – Pelvic Rehabilitation Medicine (PRM) is proud to welcome Dr. Amro Elfeky, a highly skilled gynecologic surgeon specializing in endometriosis excision, to PRM’s Centers of Excellence in Houston and Dallas. With expertise in minimally invasive and robotic-assisted surgery, Dr. Elfeky performs over 200 complex procedures annually, ensuring endometriosis patients receive precise and effective treatment.
Dr. Elfeky is committed to early diagnosis and a multimodal treatment strategy for endometriosis patients. He believes in a thorough evaluation of each patient’s symptoms and goals, ensuring a personalized, multidisciplinary care plan that maximizes outcomes. His approach integrates prehabilitation and rehabilitation through the PRM Protocol™, working alongside our team of pelvic pain specialists to support optimal recovery and long-term relief.
Having previously led specialized endometriosis centers, Dr. Elfeky has extensive experience collaborating with experts in fertility, gastrointestinal health, and mental health to enhance patient outcomes. Recognizing the complexity of endometriosis, he prioritizes a team-based approach to address all facets of the disease, ensuring that no symptom goes unaddressed.
Fertility is a significant focus in Dr. Elfeky’s treatment philosophy. Chronic inflammation and multiple prior surgeries can negatively impact fertility, which is why he often collaborates with reproductive endocrinologists to develop tailored treatment plans. By addressing endometriosis through a combination of surgical excision and additional supportive treatments, Dr. Elfeky strives to maximize symptom relief and prolong symptom-free intervals.
His philosophy is clear: surgical excision is the foundation of endometriosis treatment, but to achieve the best results, it must be supplemented with additional therapies. By capitalizing on this primary intervention and incorporating pelvic physical therapy, pain management, and hormonal regulation, Dr. Elfeky ensures patients experience the most comprehensive relief possible.
Dr. Elfeky is fluent in Arabic, furthering PRM’s mission to make specialized endometriosis care more accessible to diverse communities. By joining PRM’s Centers of Excellence in Houston and Dallas, he brings his expertise to patients in need of comprehensive, cutting-edge care for endometriosis.
With a dedication to reducing the time patients spend suffering and improving their quality of life, Dr. Elfeky is an invaluable addition to the PRM team. His deep understanding of endometriosis and commitment to a holistic, patient-centered approach will help countless individuals regain control of their health and well-being.
###
About Pelvic Rehabilitation Medicine (PRM)
PRM is a national, multi-disciplinary physician practice specializing in the treatment of chronic pelvic pain—a condition affecting 15% of women and 10% of men. Founded in 2017, PRM delivers care through its proprietary, office-based PRM Protocol™, a non-surgical treatment series designed to safely and effectively relieve pain from conditions such as endometriosis, pelvic floor dysfunction, and post-surgical pelvic pain. Led by Co-Founder and Chief Medical Officer Dr. Allyson Shrikhande, a leading physiatrist in pelvic pain, and CEO Dr. Gautam Shrikhande, a Harvard- and Columbia-trained vascular surgeon, PRM has grown to serve patients in 14 markets nationwide. With a commitment to innovation and patient-centered care, PRM’s National Centers of Excellence drive ongoing patent care for endometriosis, education, and advanced diagnostics to improve outcomes in this underserved area of medicine.
Learn more at www.pelvicrehabilitation.com.
Media Contact:
Theresa Porcaro
PRM
tporcaro@pelvicrehabilitation.com
+1 561-337-1185
### ### ###
CONTACT: Theresa Porcaro Pelvic Rehabilitation Medicine 561-337-1185 tporcaro@pelvicrehabilitation.com
- NOTICE TO DISREGARD — Choice Renovations Canada Inc - June 24, 2025
- Hims & Hers Health, Inc. Shareholders Who Lost Money on Their Investment are Encouraged to Contact Johnson Fistel about the Class Action Investigation - June 24, 2025
- LightWave Acquisition Corp. Announces Pricing of $187,500,000 Initial Public Offering - June 24, 2025
